Replies to post #348069 on Amarin Corp Plc (AMRN)

[sstyles]

Great post.

[Number sleven]

CBB, You are fixated on this concept of a big pharma buy out. At the moment I think that is unlikely. As far as I am concerned unwanted. In no way was the cash raise a "poor move". Without it the European expansion would not be possible. Vascepa has great value as a product. The new CEO has the skill set to sell that product.
Sleven,